# The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

> **NCT01809340** · PHASE2 · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 29 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Placebo
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT01809340
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** study team decision because of IP supply issue and necessary amendment to protocol
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01809340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01809340, "The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01809340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*